ZNF528-AS1: A Potential Drug Target and Biomarker (G102724105)

ZNF528-AS1: A Potential Drug Target and Biomarker

ZNF528-AS1, also known as ZNF528, is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is a key regulator of the stem-cell cycle and has been involved in the development of various diseases, including cancer. ZNF528-AS1 has been shown to promote the proliferation of cancer cells and has been identified as a potential therapeutic target.

The ZNF528-AS1 gene

The ZNF528-AS1 gene is located on chromosome 6p12 and has a length of approximately 230 nucleotides. It encodes a non-coding RNA molecule that has been shown to play a role in the regulation of the stem-cell cycle. ZNF528-AS1 has been shown to interact with various proteins, including the transcription factor, p53, and the protein, cyclin D1.

The role of ZNF528-AS1 in the stem-cell cycle

ZNF528-AS1 has been shown to play a key role in the regulation of the stem-cell cycle. It has been shown to promote the G1 phase of the cell cycle and to inhibit the S phase. This means that it promotes the growth and development of stem cells, while inhibiting their differentiation into mature cells. ZNF528-AS1 has also been shown to regulate the number of cells that have access to the DNA, which is crucial for the development and maintenance of stem cells.

The potential therapeutic benefits of ZNF528-AS1

The potential therapeutic benefits of ZNF528-AS1 are numerous. If it can be successfully targeted and inhibited, it has the potential to be used as a treatment for various diseases, including cancer. ZNF528-AS1 has been shown to promote the proliferation of cancer cells, which makes it a potential target for cancer therapies. By inhibiting the activity of ZNF528-AS1, it may be possible to kill or slow the growth of cancer cells.

In addition to its potential as a cancer therapeutic, ZNF528-AS1 has also been identified as a potential biomarker. Its regulation of the stem-cell cycle has been shown to be altered in various diseases, including cancer. By measuring the levels of ZNF528-AS1 in cancer cells or tissue samples, it may be possible to identify new biomarkers for cancer diagnosis or treatment.

The development of ZNF528-AS1 inhibitors

The development of ZNF528-AS1 inhibitors is an active area of research. Researchers are working to identify small molecules or other compounds that can inhibit the activity of ZNF528-AS1 and prevent its regulation of the stem-cell cycle. These compounds are then being tested for their potential as cancer therapies or as biomarkers for cancer diagnosis.

Conclusion

ZNF528-AS1 is a non-coding RNA molecule that has been shown to play a key role in the regulation of the stem-cell cycle. Its regulation of the stem-cell cycle has been implicated in the development of various diseases, including cancer. The potential therapeutic benefits of ZNF528-AS1 are numerous, and the development of ZNF528-AS1 inhibitors is an active area of research. Further research is needed to fully understand the role of ZNF528-AS1 in the regulation of the stem-cell cycle and its potential as a drug target and biomarker.

Protein Name: ZNF528 Antisense RNA 1

The "ZNF528-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF528-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZNF529 | ZNF529-AS1 | ZNF530 | ZNF532 | ZNF534 | ZNF536 | ZNF540 | ZNF541 | ZNF542P | ZNF543 | ZNF544 | ZNF546 | ZNF547 | ZNF548 | ZNF549 | ZNF550 | ZNF551 | ZNF552 | ZNF554 | ZNF555 | ZNF556 | ZNF557 | ZNF558 | ZNF559 | ZNF559-ZNF177 | ZNF560 | ZNF561 | ZNF561-AS1 | ZNF562 | ZNF563 | ZNF564 | ZNF565 | ZNF566 | ZNF566-AS1 | ZNF567 | ZNF568 | ZNF569 | ZNF56P | ZNF57 | ZNF570 | ZNF571 | ZNF571-AS1 | ZNF572 | ZNF573 | ZNF574 | ZNF575 | ZNF576 | ZNF577 | ZNF578 | ZNF579 | ZNF580 | ZNF582 | ZNF582-DT | ZNF583 | ZNF584 | ZNF585A | ZNF585B | ZNF586 | ZNF587 | ZNF587B | ZNF589 | ZNF592 | ZNF593 | ZNF594 | ZNF594-DT | ZNF595 | ZNF596 | ZNF597 | ZNF598 | ZNF599 | ZNF600 | ZNF603P | ZNF605 | ZNF606 | ZNF607 | ZNF608 | ZNF609 | ZNF610 | ZNF611 | ZNF613 | ZNF614 | ZNF615 | ZNF616 | ZNF618 | ZNF619 | ZNF620 | ZNF621 | ZNF622 | ZNF623 | ZNF624 | ZNF625 | ZNF625-ZNF20 | ZNF626 | ZNF627 | ZNF628 | ZNF629 | ZNF630 | ZNF638 | ZNF639 | ZNF641